Terms: = Pancreatic cancer AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS
137 results:
1. Exosomal HSPB1, interacting with fus protein, suppresses hypoxia-induced ferroptosis in pancreatic cancer by stabilizing Nrf2 mRNA and repressing P450.
Zhang L; Yang L; Du K
J Cell Mol Med; 2024 May; 28(9):e18209. PubMed ID: 38682349
[TBL] [Abstract] [Full Text] [Related]
2. Neoadjuvant chemotherapy is associated with suppression of the B cell-centered immune landscape in pancreatic ductal adenocarcinoma.
Rupp L; Dietsche I; Kießler M; Sommer U; Muckenhuber A; Steiger K; van Eijck CWF; Richter L; Istvanffy R; Jäger C; Friess H; van Eijck CHJ; Demir IE; Reyes CM; Schmitz M
Front Immunol; 2024; 15():1378190. PubMed ID: 38629072
[TBL] [Abstract] [Full Text] [Related]
3. Tumor suppression effect of ultrasound-sensitive nanoparticles with focused ultrasound in a pancreas cancer xenograft model.
Kim S; Lee JY; Park EJ; Ahn YD; Cheon Y; Sim W; Lee HJ
Eur Radiol Exp; 2024 Mar; 8(1):39. PubMed ID: 38503996
[TBL] [Abstract] [Full Text] [Related]
4. Photosensitive Hydrogel with Temperature-Controlled Reversible Nano-Apertures for Single-Cell Protein Analysis.
Xie H; Guo W; Jiang H; Zhang T; Zhao L; Hu J; Gao S; Song S; Xu J; Xu L; Sun X; Ding Y; Jiang L; Ding X
Adv Sci (Weinh); 2024 May; 11(19):e2308569. PubMed ID: 38483955
[TBL] [Abstract] [Full Text] [Related]
5. Characterization of lymphocyte-rich hepatocellular carcinoma and the prognostic role of tertiary lymphoid structures.
Ahn B; Ahn HS; Shin J; Jun E; Koh EY; Ryu YM; Kim SY; Sung CO; Shim JH; Hong J; Kim K; Kang HJ
Liver Int; 2024 May; 44(5):1202-1218. PubMed ID: 38363048
[TBL] [Abstract] [Full Text] [Related]
6. Translational and oncologic significance of tertiary lymphoid structures in pancreatic adenocarcinoma.
Gao Z; Azar J; Zhu H; Williams-Perez S; Kang SW; Marginean C; Rubinstein MP; Makawita S; Lee HS; Camp ER
Front Immunol; 2024; 15():1324093. PubMed ID: 38361928
[TBL] [Abstract] [Full Text] [Related]
7. Impact of Mutations in Subunit Genes of the Mammalian SWI/SNF Complex on Immunological Tumor Microenvironment.
Hozumi C; Iizuka A; Ikeya T; Miyata H; Maeda C; Ashizawa T; Nagashima T; Urakami K; Shimoda Y; Ohshima K; Muramatsu K; Sugino T; Shiomi A; Ohde Y; Bando E; Furukawa K; Sugiura T; Mukaigawa T; Nishimura S; Hirashima Y; Mitsuya K; Yoshikawa S; Tsubosa Y; Katagiri H; Niwakawa M; Yamaguchi K; Kenmotsu H; Akiyama Y
Cancer Genomics Proteomics; 2024; 21(1):88-101. PubMed ID: 38151294
[TBL] [Abstract] [Full Text] [Related]
8. The enrichment of the gut microbiota Lachnoclostridium is associated with the presence of intratumoral tertiary lymphoid structures in hepatocellular carcinoma.
Zhao R; Li J; Chen B; Zhao J; Hu L; Huang K; Chen Q; Yao J; Lin G; Bao L; Lu M; Wang Y; Chen G; Wu F
Front Immunol; 2023; 14():1289753. PubMed ID: 38116013
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic value of tertiary lymphoid structures (tls) in digestive system cancers: a systematic review and meta-analysis.
Sun H; Shi Y; Ran H; Peng J; Li Q; Zheng G; He Y; Liu S; Chang W; Xiao Y
BMC Cancer; 2023 Dec; 23(1):1248. PubMed ID: 38110876
[TBL] [Abstract] [Full Text] [Related]
10. Correlation of Vein-Rich Tumor Microenvironment of Intrahepatic Cholangiocarcinoma With Tertiary Lymphoid Structures and Patient Outcome.
Doi N; Ino Y; Fuse M; Esaki M; Shimada K; Hiraoka N
Mod Pathol; 2024 Feb; 37(2):100401. PubMed ID: 38043787
[TBL] [Abstract] [Full Text] [Related]
11. LINC01133 can induce acquired ferroptosis resistance by enhancing the FSP1 mRNA stability through forming the LINC01133-fus-FSP1 complex.
Wang S; Chen J; Li P; Chen Y
Cell Death Dis; 2023 Nov; 14(11):767. PubMed ID: 38007473
[TBL] [Abstract] [Full Text] [Related]
12. Sono-activated materials for enhancing focused ultrasound ablation: Design and application in biomedicine.
Liao M; Du J; Chen L; Huang J; Yang R; Bao W; Zeng K; Wang W; Aphan BC; Wu Z; Ma L; Lu Q
Acta Biomater; 2024 Jan; 173():36-50. PubMed ID: 37939816
[TBL] [Abstract] [Full Text] [Related]
13. Apoptotic Effect of Gallic Acid via Regulation of p-p38 and ER Stress in PANC-1 and MIA PaCa-2 Cells pancreatic cancer Cells.
Kim JW; Choi J; Park MN; Kim B
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894916
[TBL] [Abstract] [Full Text] [Related]
14. Exploring dual effects of dinutuximab beta on cell death and proliferation of insulinoma.
Karatug Kacar A
Chem Biol Drug Des; 2024 Jan; 103(1):e14368. PubMed ID: 37802653
[TBL] [Abstract] [Full Text] [Related]
15. Expression of GRP78 and its copartners in HEK293 and pancreatic cancer cell lines (BxPC-3/PANC-1) exposed to MRI and CT contrast agents.
Azzawri AA; Yildirim IH; Yegin Z; Dusak A
Nucleosides Nucleotides Nucleic Acids; 2024; 43(5):391-416. PubMed ID: 37787049
[TBL] [Abstract] [Full Text] [Related]
16. Clinical trial protocol for PanDox: a phase I study of targeted chemotherapy delivery to non-resectable primary pancreatic tumours using thermosensitive liposomal doxorubicin (ThermoDox®) and focused ultrasound.
Spiers L; Gray M; Lyon P; Sivakumar S; Bekkali N; Scott S; Collins L; Carlisle R; Wu F; Middleton M; Coussios C
BMC Cancer; 2023 Sep; 23(1):896. PubMed ID: 37741968
[TBL] [Abstract] [Full Text] [Related]
17. Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy.
Zou X; Guan C; Gao J; Shi W; Cui Y; Zhong X
Front Immunol; 2023; 14():1222719. PubMed ID: 37529035
[TBL] [Abstract] [Full Text] [Related]
18. pancreatic follicular dendritic cell sarcoma: a rare case report and systematic literature review of 7 cases.
Li X; Gu J; He Q; Han S; Wu H
World J Surg Oncol; 2023 Jul; 21(1):212. PubMed ID: 37480085
[TBL] [Abstract] [Full Text] [Related]
19. High endothelial venule is a prognostic immune-related biomarker in patients with resected intrahepatic cholangiocarcinoma.
Zhou Y; Gu Q; Zhu L; Zhang S; Wu H; Pu X; Jiang C; Chen J
Cell Prolif; 2023 Dec; 56(12):e13513. PubMed ID: 37401015
[TBL] [Abstract] [Full Text] [Related]
20. Characterization of intratumoral tertiary lymphoid structures in pancreatic ductal adenocarcinoma: cellular properties and prognostic significance.
Zou X; Lin X; Cheng H; Chen Y; Wang R; Ma M; Liu Y; Dai Z; Tasiheng Y; Yan Y; Hou Q; Ding F; Chen H; Yu X; Wang X; Liu C
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37364934
[TBL] [Abstract] [Full Text] [Related]
[Next]
